| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a5555737f0b3e17e5497a3aeb6a49cd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3519 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21047 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2014-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b8db32469e2d686201f05857a277ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe554940a351fb349c8a43784b5f31a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f37434069037d80bb843f4bf225620a |
| publicationDate |
2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150103280-A |
| titleOfInvention |
Age-related macular degeneration treatment |
| abstract |
The present invention relates to RNA interference (RNAi) agonists and the use of such RNAi agonists to treat age-related macular degeneration, and to pharmaceutical compositions containing the RNAi agonists of the present invention. RNAi agonists are DNA-induced RNA interference (ddRNAi) agonists having an expression cassette or construct for expressing intracellular (including in vivo) such agonists to inhibit, prevent or reduce the expression of AMD- Lt; / RTI > molecule). Preferably the AMD-associated gene is associated with wet AMD. |
| priorityDate |
2013-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |